ALIS MEDICAL : revenue, balance sheet and financial ratios
ALIS MEDICAL is a French company
founded 21 years ago,
specialized in the sector Activités des sièges sociaux.
Based in COURBEVOIE (92400),
this company of category ETI
shows in 2020 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - ALIS MEDICAL (SIREN 479666737)
Indicator
2024
2020
2019
2018
2017
2016
2015
2014
2013
2012
Revenue
N/C
1 570 166 €
1 622 091 €
1 803 171 €
1 626 337 €
N/C
N/C
N/C
N/C
N/C
Net income
12 576 €
124 203 €
210 360 €
249 633 €
255 318 €
269 235 €
273 174 €
696 818 €
2 905 411 €
499 410 €
EBITDA
N/C
137 711 €
240 654 €
303 867 €
348 981 €
-1 330 981 €
-1 110 497 €
-1 074 259 €
-892 833 €
N/C
Net margin
N/C
7.9%
13.0%
13.8%
15.7%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, ALIS MEDICAL generates positive net income of 13 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2012-2024: 499 k€ -> 13 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
12 576 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 18%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 76%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
18.284%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
76.137%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2012
2013
2014
2015
2016
2017
2018
2019
2020
2024
Debt ratio
160.974
158.687
5.433
5.387
11.967
12.757
12.836
16.16
16.104
18.284
Financial autonomy
37.065
37.652
90.314
90.566
85.754
84.901
84.465
82.431
82.894
76.137
Repayment capacity
None
2.491
0.607
1.773
16.614
4.909
5.204
8.008
9.864
None
Cash flow / Revenue
None%
None%
None%
None%
None%
15.64%
13.737%
12.755%
10.79%
None%
Sector positioning
Debt ratio
18.282024
2019
2020
2024
Q1: 0.06
Med: 14.64
Q3: 89.5
Average+12 pts over 3 years
In 2024, the debt ratio of ALIS MEDICAL (18.28) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
76.14%2024
2019
2020
2024
Q1: 11.6%
Med: 51.97%
Q3: 85.23%
Good-7 pts over 3 years
In 2024, the financial autonomy of ALIS MEDICAL (76.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
9.86 years2020
2019
2020
Q1: 0.0 years
Med: 0.5 years
Q3: 5.15 years
Average
In 2020, the repayment capacity of ALIS MEDICAL (9.86) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 706.52. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
706.523
Liquidity indicators evolution ALIS MEDICAL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2012
2013
2014
2015
2016
2017
2018
2019
2020
2024
Liquidity ratio
1899.634
296.91
1377.421
1446.562
1720.947
1632.788
1504.698
1693.088
1945.256
706.523
Interest coverage
None
-5.793
-2.354
-1.172
-0.18
1.979
1.198
1.829
12.509
None
Sector positioning
Liquidity ratio
706.522024
2019
2020
2024
Q1: 116.82
Med: 458.52
Q3: 2178.3
Good-21 pts over 3 years
In 2024, the liquidity ratio of ALIS MEDICAL (706.52) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
12.51x2020
2019
2020
Q1: -35.71x
Med: 0.0x
Q3: 3.57x
Excellent+12 pts over 2 years
In 2020, the interest coverage of ALIS MEDICAL (12.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution ALIS MEDICAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2012
2013
2014
2015
2016
2017
2018
2019
2020
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
7 038 917 €
7 624 420 €
8 398 376 €
8 584 569 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
0
Customer payment term (days)
0
0
0
0
0
346
348
381
392
0
Supplier payment term (days)
0
18
20
19
28
29
21
18
22
0
Positioning of ALIS MEDICAL in its sector
Comparison with sector Activités des sièges sociaux
Valuation estimate
Based on 103 transactions of similar company sales
in 2024,
the value of ALIS MEDICAL is estimated at
119 571 €
(range 41 056€ - 321 968€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
103 transactions
41k€119k€321k€
119 571 €Range: 41 056€ - 321 968€
NAF 5 année 2024
Valuation method used
Net Income Multiple
12 576 €
×
9.5x
=119 572 €
Range: 41 056€ - 321 969€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Activités des sièges sociaux)
Compare ALIS MEDICAL with other companies in the same sector:
Yes, ALIS MEDICAL generated a net profit of 13 k€ in 2024.
Where is the headquarters of ALIS MEDICAL ?
The headquarters of ALIS MEDICAL is located in COURBEVOIE (92400), in the department Hauts-de-Seine.
Where to find the tax return of ALIS MEDICAL ?
The tax return of ALIS MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does ALIS MEDICAL operate?
ALIS MEDICAL operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart